Periodontal Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment), Surgical Devices (Bone Implants, Bone Grafting)), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.12 Billion
CAGR (2026-2031)	7.05%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America
Market Size (2031)	USD 3.19 Billion

Market Overview

The Global Periodontal Market will grow from USD 2.12 Billion in 2025 to USD 3.19 Billion by 2031 at a 7.05% CAGR. Periodontal products encompass a specialized range of dental therapeutics and devices designed for the prevention, diagnosis, and treatment of gum diseases, including gingivitis and periodontitis. This sector includes systemic and local antimicrobials, surgical instrumentation, and regenerative materials such as bone grafts. The market’s expansion is fundamentally supported by an aging global population, which is naturally more susceptible to periodontal degeneration, and the increasing clinical recognition of the bi-directional relationship between oral health and systemic conditions like diabetes. These factors create a sustained demand for effective management solutions distinct from cosmetic dental trends.

However, the market faces a significant impediment regarding the widespread lack of adequate reimbursement policies, which sustain high out-of-pocket costs and deter patient compliance in many regions. This financial barrier limits access to advanced therapies and long-term maintenance protocols. According to the FDI World Dental Federation, in 2025, severe periodontal diseases were estimated to affect more than one billion cases worldwide, underscoring a critical gap between the massive disease burden and the economic accessibility of necessary treatment.

Key Market Drivers

Escalating Global Prevalence of Periodontal Diseases acts as the primary catalyst for market growth, creating a foundational need for continuous therapeutic intervention. As gum disorders progress from gingivitis to severe periodontitis, the clinical burden necessitates a higher volume of diagnostic screenings, scaling procedures, and pharmacological treatments. This volume-driven demand is particularly acute in developing regions where oral hygiene education lags, yet it remains a persistent challenge in developed nations due to aging demographics. Supporting this trend, according to the National Institutes of Health, July 2025, in the 'Global, regional, and national burden of periodontal diseases' study, global estimates indicated approximately 89.6 million incident cases of periodontal diseases in a single year, highlighting the continuous influx of new patients requiring care.

Growing Awareness of the Systemic Link Between Oral Health and Chronic Diseases is fundamentally reshaping treatment protocols and patient referral patterns. Clinicians are increasingly adopting a holistic approach, where periodontal management is integrated into the care plans for systemic conditions such as cardiovascular disease and diabetes mellitus. This paradigm shift elevates periodontal care from elective dental hygiene to essential medical management, thereby driving insurance utilization and treatment compliance. According to the European Federation of Periodontology, November 2024, in the 'EFP calls attention to interactions between diabetes and gum disease' report, studies demonstrate that individuals with diabetes possess a threefold higher risk of developing severe gum disease compared to non-diabetics. Furthermore, the economic viability of this sector is reflected in broader dental consumption trends; according to the American Dental Association, in 2025, consumer dental spending recorded a 3% increase, signaling sustained financial commitment to oral healthcare.

Download Free Sample Report

Key Market Challenges

The widespread lack of adequate reimbursement policies acts as a substantial impediment to the growth of the Global Periodontal Market by creating a severe financial barrier for both patients and dental providers. Limited insurance coverage for periodontal procedures forces patients to bear high out-of-pocket costs, which frequently results in the refusal or delay of essential treatments. This economic constraint directly reduces the demand for advanced dental therapeutics, surgical instrumentation, and expensive regenerative materials, as patients opt for cheaper or less invasive alternatives. Furthermore, dental practices are discouraged from adopting premium periodontal technologies when compensation rates fail to cover the operational costs, leading to market stagnation despite the rising clinical need. According to the American Dental Association, in 2025, approximately 58 percent of dental practitioners identified low insurance reimbursement rates and claim denials as a primary challenge hindering their ability to maintain practice viability and deliver optimal care. This financial disconnect effectively suppresses the commercial uptake of periodontal products and restricts the broader expansion of the sector.

Key Market Trends

The Integration of Artificial Intelligence for Predictive Diagnostics is fundamentally altering the periodontal landscape by transitioning clinical workflows from subjective assessment to objective, data-driven disease management. AI algorithms now automatically quantify bone level measurements and detect early-stage radiographic bone loss with precision that surpasses traditional manual methods, thereby enhancing diagnostic accuracy and patient trust. This technological shift is directly impacting practice revenue cycles by validating treatment necessity to patients who often struggle to visualize asymptomatic gum disease, effectively closing the communication gap between clinician and patient. According to Forbes, July 2025, in the 'How AI Is Transforming Dentistry From Diagnosis To Payment' article, a market survey by Overjet revealed that 72% of patients indicated they would be more likely to accept a dentist's diagnosis and treatment plan if it were presented with AI-generated findings, underscoring the technology's critical role in converting proposed periodontal therapies into active cases.

Concurrently, the Advancement in Regenerative Tissue Engineering and Biologics is redefining therapeutic possibilities by enabling the restoration of lost periodontal support structures rather than merely arresting disease progression. Clinicians are increasingly utilizing advanced biomaterials, such as growth-factor-enhanced bone grafts and barrier membranes, to facilitate true periodontal regeneration around compromised teeth and implants. This shift towards biological preservation is sustaining robust commercial performance for major industry players, driving demand for premium regenerative portfolios despite broader economic headwinds. According to Straumann Group, February 2025, in the 'Strong 2024 performance reflects Straumann Group's strengths in innovation and execution' report, the company achieved a full-year revenue of CHF 2.5 billion, a figure significantly bolstered by the continued adoption of its premium implant and biomaterial solutions in key global markets.

Segmental Insights

The Hospitals & Clinics segment is recognized as the fastest-growing category in the Global Periodontal Market, primarily due to the rising demand for complex surgical interventions that require sterile, regulated environments. This growth is propelled by the integration of advanced diagnostic technologies and laser therapies within these facilities, which ensure superior patient outcomes for severe periodontitis cases. Additionally, hospitals increasingly serve as central referral points for multidisciplinary care, allowing for comprehensive treatment planning. Favorable reimbursement structures for procedures performed in accredited medical institutions further incentivize patients to utilize these services, thereby driving the segment's rapid expansion.

Regional Insights

North America holds the leading position in the global periodontal market primarily due to the rising prevalence of periodontal disorders and elevated healthcare spending. The region benefits from established dental infrastructure and favorable reimbursement structures that improve patient access to treatment. Furthermore, initiatives by institutions like the Centers for Disease Control and Prevention increase diagnosis rates by raising awareness regarding oral hygiene. The concentration of key industry manufacturers within the region also ensures widespread availability of diagnostics and therapeutics, further consolidating North America’s market dominance.

Recent Developments

• In April 2025, Convergent Dental introduced the Solea Perioguide, a next-generation laser application specifically engineered for minimally invasive periodontal therapy. This new product allows dental professionals to perform precise, in-pocket laser treatments for moderate to severe periodontitis, offering an alternative to traditional scaling and root planing. The launch highlighted the company's focus on enhancing patient comfort and clinical outcomes by providing a technology that facilitates soft tissue healing and reduces the need for more invasive surgical interventions in treating gum disease.
• In April 2025, ZimVie Inc. announced the launch of its Immediate Molar Implant System in the United States, featuring a specialized design to address the challenges of immediate molar replacement. The implants in this system incorporate a proprietary dual acid-etched coronal surface technology which, according to the company, is designed to reduce the risk of peri-implantitis by up to 20%. This product launch underscored the company's commitment to improving periodontal and peri-implant health by providing solutions that promote better soft tissue attachment and simplify complex clinical workflows.
• In February 2025, Curaprox, a brand of Curaden AG, launched a new chlorhexidine-free mouthwash named Perio plus zero at the AEEDC Dubai conference. The new formulation was developed to offer a microbiome-friendly alternative for periodontal maintenance, utilizing natural bioflavonoids to control plaque without the side effects often associated with traditional antiseptics, such as staining or taste alteration. The product was introduced to meet the growing demand for gentle yet effective oral care solutions that support gum health and protect the oral microbiome during long-term use.
• In April 2024, Geistlich Pharma AG, a specialist in regenerative dentistry, signed an agreement to acquire Bionnovation Biomedical, a medical technology company based in Brazil. This strategic acquisition was designed to expand the Swiss company’s portfolio of regenerative solutions, specifically adding new barrier membranes and bone substitution materials to its offerings. The collaboration aimed to strengthen Geistlich's presence in South America and emerging markets while broadening its range of biomaterials used in periodontal and implant surgeries to support bone and soft tissue regeneration.

Key Market Players

• Medtronic PLC
• Straumann AG
• The 3M Company
• Bausch Health Companies Inc.
• Dentsply Sirona Group
• Pfizer Inc.
• Novartis AG
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation

By Therapy	By End User	By Region
Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment) Surgical Devices (Bone Implants, Bone Grafting)	Hospitals & Clinics Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Periodontal Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Periodontal Market, By Therapy:

• Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment)
• Surgical Devices (Bone Implants, Bone Grafting)

• Periodontal Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

• Periodontal Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE